Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Sitagliptin Phosphate × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Letrozole 28 Fulvestrant 27 Paclitaxel 25 Trastuzumab 20 ribociclib 18 pembrolizumab 18 Capecitabine 18 trastuzumab deruxtecan 13 Specimen Handling 13 Anastrozole 13 palbociclib 12 Carboplatin 12 exemestane 11 abemaciclib 11 Tamoxifen 11 Cyclophosphamide 11 Blood Specimen Collection 11 Magnetic Resonance Spectroscopy 10 130-nm albumin-bound paclitaxel 10 pertuzumab 9 inavolisib 9 Radiotherapy 9 giredestrant 7 Surveys and Questionnaires 7 tucatinib 6 olaparib 6 Docetaxel 6 Biopsy 6 sacituzumab govitecan 5 eribulin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07436663 2026-02-27

SGLT2i/DPPi

Tanta University

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡